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Introduction. Severe leptospirosis, also known as Weil’s disease, can cause multiorgan failure with high mortality. Scoring systems
for disease severity have not been validated for leptospirosis, and there is no documented method to predict mortality. Methods.
This is a case series on 10 patients admitted to ICU for multiorgan failure from severe leptospirosis. Data were collected
retrospectively, with approval from the Institution Ethics Committee. Results. Ten patients with severe leptospirosis were admitted
in the Patras University Hospital ICU in a four-year period. Although, based on SOFA scores, predicted mortality was over 80%,
seven of 10 patients survived and were discharged from the hospital in good condition. There was no association between SAPS
II or SOFA scores and mortality, but survivors had signiﬁcantly lower APACHE II scores compared to nonsurvivors. Conclusion.
Commonly used severity scores do not seem to be useful in predicting mortality in severe leptospirosis. Early ICU admission and
resuscitationbasedonagoal-directed therapyprotocolarerecommended andmayreduce mortality.However, thisstudyislimited
by retrospective data collection and small sample size. Data from large prospective studies are needed to validate our ﬁndings.
1.Introduction
Sepsis and multiple organ failure are associated with high
ICU morbidity and mortality. Currently available organ
failure scoring systems, such as the Sequential Organ Failure
Assessment (SOFA) score can help assess organ dysfunction
over time and have been associated with ICU mortality.
The term Leptospirosis refers to disease caused by any
leptospira, regardless of speciﬁc serotype. Leptospirosis is
thought to be the most widespread zoonosis in the world.
Weil syndrome [1, 2] is deﬁned as severe leptospirosis with
multi-organ dysfunction. Weil syndrome can cause respir-
atory failure [3], renal failure requiring hemodialysis [4],
hemorrhages, anemia, disturbances in consciousness, and
persistent fever and sepsis with high mortality, even in
previously healthy patients [5].
SOFA score has been shown to correlate with outcome in
a variety of ICU populations [6]. Therefore, use of repeated
SOFA score measures over time is a reasonable attempt to
assess the severity of organ dysfunction and predict outcome
in severe leptospirosis, even though SOFA score has not
been validated in patients with leptospirosis. However, our
experience with patients admitted to the ICU for severe
leptospirosis suggests that patients can have good outcome
despite severe multi-organ failure with high SOFA scores
and very high predicted mortality on ICU admission. This
retrospective study was conducted in an attempt to evalu-
ate whether admission SOFA scores, repeated SOFA score2 Critical Care Research and Practice
measurements over time, admission SAPS II or admission
APACHE II scores can help predict mortality in severe
leptospirosis.
2.MaterialsandMethods
2.1. Study Design and Data Collection. This retrospective
study consisted of chart review and data extraction from all
conﬁrmed leptospirosis cases admitted to our ICU over a
4-year period. The project was approved by the Institution
Ethics Committee. Demographic data and data on clinical
history, physical examination at the time of ICU admission,
initial and follow-up laboratory values, diagnostic tests
used to conﬁrm leptospirosis and treatment provided were
collected from each medical record, and stored without any
personally identiﬁable information in a secure electronic
database. SOFA scores on admission and every day until
death or discharge from the ICU were also recorded. Calcu-
lation of daily SOFA scores was based on the most abnormal
value for each SOFA score parameter each day [7]. APACHE
II and SAPS II were also calculated on the day of ICU
admission. When patients were sedated and intubated we
assumed they did not have any CNS abnormalities.
2.2. Statistical Analysis. Because data distribution was
skewed and violated normality, comparisons between sur-
vivorsandnon-survivorsweredonewiththenon-parametric
Mann-Whitney U test. Observed mortality was compared
with expected mortality using Fisher’s exact test. Data anal-
ysis was done with the SPSS version 17.0 statistical software
package (SPSS Inc, Chicago, IL). P<0.05 was considered
signiﬁcant for all comparisons. Fisher’s exact test was done
using the STATCALC component of the Epi Info statistics
software package (freely available from the Centers for
Disease Control at http://www.cdc.gov/Epiinfo/,J a n u a r y5 ,
2010).
3. Results
3.1. Demographic and Clinical Data. Ten patients (9 men,
one woman) were admitted to the ICU for multi-organ
failure due to severe leptospirosis between 2006 and 2009.
All patients lived and worked in rural areas, and therefore
were at risk for occupational exposure to leptospira. Because
data did not have a normal distribution, data in Table 1 are
presented as median (minimum, maximum).
3.2. Initial Diagnosis and ICU Therapy. All patients in this
case series were admitted to the ICU because of severe
respiratory insuﬃciency, acute renal failure, hypotension,
coagulopathy, coma or any combination of the above. All
patients presented in the Emergency Department with a
GCS of 15, except a female patient who had a GCS of 6,
intubated initially in the ED and had the shortest ICU length
of stay (died after 4 days). None of the patients developed
lung hemorrhages or cardiac rhythm abnormalities either on
admissionorduringICUstay.Demographicandclinicaldata
for each patient are presented in Table 2.
Table 1: Demographic and Clinical Data on ICU admission in sur-
vivors and non-survivors.
Variable Overall Survivors Non-survivors
Age 54 (22, 74) 56 (22, 74) 52 (50, 58)
ICU LOS 10.5 (4,37) 17 (5, 37) 8 (4, 13)
PaO2/FiO2 155 (70, 338) 215 (142, 338) 105 (70, 150)
Platelet count 35 (15, 82) 43 (20, 82) 21 (15, 28)
Bilirubin 8.64 (1, 17) 9.33 (1, 14) 7 (2, 17)
Creatinine 2.9 (1, 6) 3.7 (1, 6) 3 (3, 4)
Ventilator days 6 (0, 27) 0 (0, 27) 8 (4, 13)
SOFA score 15.5 (9, 18) 14 (9, 18) 17 (17, 18)
PaO2/FiO2,withPaO2measured in mmHg, Platelet count expressed in thou-
sands/mm3, Bilirubin measured as mg/dL, Creatinine measured as mg/dL.
Values are presented as median (minimum, maximum).
At the time of ICU admission, the diagnosis of lep-
tospirosis was suspected on the basis of history and clinical
presentation. Diagnosis was later conﬁrmed on all patients
by enzyme-linked immunosorbent assay (ELISA) [8]. Treat-
ment in all 10 cases included broad spectrum antibiotics,
oxygen supplementation by face mask, CPAP or intubation
and mechanical ventilation, and support of all failing sys-
tems. Hemodynamic resuscitation and stabilization was
based on the goal-directed therapy protocol described by
Rivers et al. [9], in an attempt to optimize vital organ per-
fusion and oxygen delivery to peripheral tissues.
3.3. Disease Severity Scores on ICU Admission. All nine men
werefullyawakeandorientedonICUadmission(GCS =15),
whereas the only female patient was comatose (GCS = 6),
without evidence of meningeal infection on CSF testing.
On ICU admission, oxygenation impairment was sig-
niﬁcantly worse in non-survivors (n = 3) compared to
survivors (n = 7): Median PaO2/FiO2 was 105 in non-
survivors versus 215 in survivors (P = 0.04). Similarly,
admission platelet count was signiﬁcantly lower in non-
survivors (median 21,000) versus survivors (median 43,000,
P = 0.05).
The cause of death in all three non-survivors was
multiple organ failure and increased need for inotropic and
vasoactive agents as shown in Table 2. No arrhythmias were
recorded during their ICU stay.
SOFA, APACHE II and SAPS II on ICU admission are
presented in Table 3. With regards to mortality, although the
predicted mortality based on initial SOFA score was high,
only 3 of 10 patients died.
4. Discussion
4.1. Leptospirosis in the ICU. Leptospirosis is a worldwide
zoonosis [10, 11], and has been reported in most parts of the
world, including North America (USA [8, 12, 13]), Europe
(Germany [14], The Netherlands [15], Portugal [16, 17],
Greece [18], Serbia [19], Turkey [20, 21]), The Middle
East (Israel [22, 23]), Central and South America (BrazilCritical Care Research and Practice 3
Table 2: Demographic and clinical data for each patient.
Case
no. Age ICU
LOS
Initial
GCS PaO2/FiO2
Inotrope/vasopressor
Days
Serum
Cr Bili PLT ∗103 SOFA/Predicted
mortality
APACHE
II/Predicted
Mortality
SAPS
II/predicted
mortality
Outcome
1 50 8 15 105 D 8 2.9 16.9 21 17/95 16/25 50/50 Death
2 56 32 15 160 N 25 5.4 10.02 20 18/95 17/25 68/75 Good
3 52 37 15 150 D12 2.9 7.08 50 14/95 16/25 65/75 Good
4 22 17 15 142 D 6 6.1 10.6 30 17/95 13/15 50/50 Good
5 58 4 6 150 N40 2.5 1.52 28 17/95 18/25 34/15 Death
6 67 6 15 215 D3 2.7 1.23 82 9/33 4/4 22/5 Good
7 70 6 15 338 D3 5.6 14 40 14/95 6/8 32/10 Good
8 52 13 15 70 D10, N20 3.8 7 15 18/95 18/25 52/50 Death
9 52 5 15 300 D3 0.8 12.1 49 10/50 6/8 30/10 Good
10 74 31 15 300 None 4.5 8.64 43 10/50 8/8 32/10 Good
GCS: Glasgow Coma Scale, D: Dopamine, N:Norepinephrine, Bili: Total bilirubin, PLT: Platelet count, HD: Hemodialysis.
Table 3: SOFA, APACHE II and SAPS II on ICU admission.
Case no. Age Sex (M/F) Admission SOFA Admission APACHE II Admission SAPS II Survived (Y/N)
1 50 M 17 16 50 N
2 56 M 18 17 68 Y
3 52 M 14 16 65 Y
4 22 M 17 13 50 Y
5 58 F 17 18 34 N
66 7 M9 4 2 2 Y
7 7 0 M 1 463 2 Y
8 52 M 18 18 52 N
9 5 2 M 1 063 0 Y
10 74 M 10 8 32 Y
[4, 24, 25], Cuba [26], Nicaragua [27], Trinidad and Tobago
[28], West Indies [29]), Asia (India [30, 31], Thailand [32],
Indonesia[3]),Africa(Egypt[33,34],Nigeria[35,36],South
Africa [37]), Australia [38]a n dN e wZ e a l a n d[ 39, 40]. Lep-
tospirosisischaracterizedbygreatclinicalvariability,ranging
from a mild ﬂu-like illness to life-threatening multi-organ
failure. There are no established criteria for early identiﬁca-
tion of the severe forms of leptospirosis, but prompt recogni-
tion of severe cases, followed by appropriate timely interven-
tion may contribute to improved morbidity and mortality.
Several studies attempted to identify prognostic factors asso-
ciated with mortality, but diﬀerent authors have reached dif-
ferentconclusions.Dupontdemonstratedthatdyspnea,olig-
uria, low white blood cell count, repolarization abnormal-
ities on electrocardiogram, and alveolar inﬁltrates on chest
radiographs were independently associated with mortality
[29],whereasEsenetal.[20]demonstratedthatpatientswith
altered mental status and hyperkalemia on hospital admis-
sion are at high risk for mortality and should be followed
up in an ICU. A prospective cohort study by Panaphut et al.
[32] suggested that oliguria, hyperkalemia, pulmonary rales
or hypotension on admission are associated with high mor-
tality, a study by Marotto et al. [25] identiﬁed hemodynamic
disturbance,renaldysfunctionandhyperkalemiaasvariables
associated with mortality. In addition, a large recent study
from India by Pappachan et al. [41] used logistic regres-
sion and identiﬁed pulmonary and central nervous system
involvement as signiﬁcant predictors of death, whereas a
large recent study from Indonesia [3] identiﬁed pulmonary
involvement as a strong independent predictor of mortality.
Despite diﬀerences between studies, most authors agree that
intensive care and early intervention should be provided for
patients who present with risk factors and in cases where
there is high index of clinical suspicion for leptospirosis, but
diagnosis has not been conﬁrmed by the laboratory.
Mortality in leptospirosis has been reported to be up to
55% in diﬀerent studies, but varies depending on case mix
and severity of organ dysfunction. In a study from Brazil
by Vieira [42], where all 35 patients presented with ARF,
required mechanical ventilation and developed multi-organ
failure, mortality was 51%. [42]. In another study from
India, all 60 leptospirosis patients who were admitted to the
ICU had evidence of severe sepsis, 46 of 60 had multiple
organdysfunction,26of60requiredventilatorysupport,and
mortality was 52% [30]. In contrast, although only patients
with severe leptospirosis were admitted to the ICU in our
study, mortality was lower (3 of 10 patients, 30%) compared
to previous reports.4 Critical Care Research and Practice
4.2. SOFA Score and Other Severity Scoring Systems. Cur-
rently available outcome prediction models include the
APACHE II (Acute Physiology and Chronic Health Evalu-
ation II), SAPS II (Simpliﬁed Acute Physiology Score II)
and MPM (Mortality Probability Models). These systems
calculate a prediction based on values recorded within
the ﬁrst 24 hours after ICU admission. The APACHE-II
score estimates ICU mortality based on clinical signs and
laboratory values, but also takes into account both acute
and chronic patient diseases. The SAPS II is a severity of
disease classiﬁcation system, and it is mostly used to describe
morbidity and outcome. Because of the need to evaluate
changes in patient status over time, two scoring systems were
developed, the Multiple Organ Dysfunction Score (MODS)
and the Sequential Organ Failure Assessment (SOFA) scores
[7,43],whicharecalculatedonadmissionandevery24hours
until patient death or discharge from the ICU.
The MODS was developed based on a literature review
of all studies related to multiple organ dysfunction published
between 1969 and 1993, to determine which characteristics
had been used to deﬁne organ failure. The SOFA score
was created during a consensus conference organized by the
European Society of Intensive Care and Emergency Med-
icine.Bothscorescalculateasummaryvalueforthedegreeof
dysfunction for six organs (respiratory, hematologic, cardio-
vascular, liver, renal and central nervous system). For SOFA
score, this evaluation includes PO2/FiO2 ratio, levels of
serum creatinine, levels of serum bilirubin, platelet count,
assessment of neurologic status (Glasgow Coma Scale) and
assessment of the cardiovascular system (doses of adrenergic
agents administered for hypotension). The main diﬀerence
between the MODS and the SOFA is in the evaluation
of cardiovascular function. In MODS, the cardiovascular
assessment is based on the pressure adjusted heart-rate
(PAR), deﬁned as the product of the heart rate (HR) multi-
plied by the ratio of the right atrial pressure (RAP) to the
mean arterial pressure (MAP), whereas the SOFA score is
calculated based on mean arterial pressure and the need for
vasopressors.
Results from many clinical studies show that the MODS
and the SOFA score correlate well with outcome in terms
of mortality [44], and also correlate with the APACHE II
score. Of note, compared to the APACHE II score, both
MODS and SOFA score were better predictors of mortality
in the subgroup of patients with shock. With regards to
the SOFA score, although this was not created for use as
predictor of mortality, SOFA score changes over time have
been associated with ICU mortality. In each 24-hour period,
the most abnormal value for each parameter was used in the
calculation of the SOFA score [7].
4.3.LeptospirosisintheICU:OurResults. Theﬁndingsofour
study come in line with the results of a retrospective study by
Ittyachen [31] on 104 cases with clinical suspicion of severe
leptospirosis. In this study, leptospirosis was serologically
conﬁrmed in 53 (50.7%) cases, and mortality was 26.8%
in the sero-negative group versus 3.8% in the sero-positive
group. The discordance between observed mortality and
SOFA-predictedmortalityinourstudycouldbeattributedto
statistical error due to our small number of patients or errors
in calculating mortality predicted by SOFA score. Other
plausible explanations include real diﬀerences between our
leptospirosis ICUpatient population andtheSOFAreference
population [43] or greater potential for organ recovery when
organ dysfunction is caused by leptospirosis. Admission
SOFA scores were high in both survivors and non-survivors.
SOFA scores declined during the ﬁrst 5 ICU days due to
restoration of platelet count and hemodynamic stabilization
inallpatients.However,improvementwasmorepronounced
i ns u r v i v o r s .O v e rt i m e ,S O F As c o r e sc o n t i n u e dt oi m p r o v e ,
due to gradual restoration of respiratory, renal and hepatic
function in survivors, whereas SOFA scores remained high
until death in non-survivors. However, the results of this
small,retrospectivestudyshouldbeinterpretedwithcaution,
because the retrospective nature of our study and the small
sample size are major shortcomings of this work.
5. Conclusion
Leptospirosis is a severe disease that can progress to multi-
organ failure requiring ICU care, with high predicted mor-
tality. Although SOFA score can be used as a tool to assess
disease severity in leptospirosis, our limited data suggest
that SOFA and other commonly used severity scores may
not be good predictors of mortality. Our ﬁndings suggest
that we should be optimistic in cases of severe leptospirosis
with multiple organ failure, as in this series critically ill
leptospirosis patients with high disease severity scores had
a good outcome. Prospective multi-center studies with large
numbers of patients are needed to validate our ﬁndings.
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